Products

What will AGI do for Altrenogest?

This classification denotes a progestagen with the molecular formula C21H26O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2U0X0JA2NB, chemically known as 17-alpha-allyl-estratriene-4,9,11,17-beta-ol-3-one but generally known as altrenogest, which bears US NIH Compound Identifier 13324. European Medicines Agency schedules Altrenogest in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05381MIG. The term ALTRENOGEST is an International Non-Proprietary Name. ALTRENOGEST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule altrenogest under HS 29372300 and SITC 54153. As of Q4 2014, ALTRENOGEST remains the US FDA Preferred Term for this commodity. Altrenogest bears US NLM identifiers UMLS ID C0102819 and NCI Concept Code C83529. SMILES: OC1(C2(C(C3C(=C4C(=CC(=O)CC4)CC3)C=C2)CC1)C)CC=C.

How AGI delivers it

Four ways AGI delivers for Altrenogest

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Altrenogest, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Altrenogest, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Altrenogest connects

measured by

  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Loss On Dryingmodel
  • Optical Rotationmodel
  • Residual Solventmodel